Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nab-Paclitaxel in ER+/HER2- Recurrent Metastatic Breast Cancer
NCT04194684Phase 2Unknown
- Sponsor
- Chinese Academy of Medical Sciences
- Start
- Dec 2019
- Primary completion
- Dec 2022
- Modality
- Small Molecules
01
Overview
A Phase 2 trial of paclitaxel in breast cancer, sponsored by Chinese Academy of Medical Sciences. Status: unknown.
02
Drugs
paclitaxel
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT04194684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04194684.